日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Tisagenlecleucel in combination with ibrutinib in adults with relapsed and/or refractory large B-cell lymphomas

Tisagenlecleucel联合ibrutinib治疗复发和/或难治性大B细胞淋巴瘤成人患者

Chavez, Julio C; Napier, Ellen; Bondanza, Attilio; Lewandowski, Andrew; Mataraza, Jennifer; Quinn, David; Kwon, Paul; Locke, Frederick L; Engels, Boris; Awasthi, Rakesh; Georgala, Petrina; Leyk, Malgorzata; Hynds, David; Moschetta, Michele; Schuster, Stephen J

Five-Year Follow-Up Analysis of ZUMA-5: Axicabtagene Ciloleucel in Relapsed/Refractory Indolent Non-Hodgkin Lymphoma

ZUMA-5 五年随访分析:Axicabtagene Ciloleucel 治疗复发/难治性惰性非霍奇金淋巴瘤

Neelapu, Sattva S; Chavez, Julio C; Sehgal, Alison R; Epperla, Narendranath; Ulrickson, Matthew L; Bachy, Emmanuel; Munshi, Pashna N; Casulo, Carla; Maloney, David G; de Vos, Sven; Reshef, Ran; Leslie, Lori A; Oluwole, Olalekan O; Yakoub-Agha, Ibrahim; Khanal, Rashmi; Rosenblatt, Joseph D; Wulff, Jacob; Shen, Rhine R; Zhang, Wangshu; Poddar, Soumya; Miao, Harry; Nikolajeva, Olga; Jacobson, Caron A

Outcomes of patients with Richter transformation who received no prior chemoimmunotherapy for their CLL

既往未接受过针对慢性淋巴细胞白血病(CLL)的化疗免疫治疗的里氏转化患者的预后

Kittai, Adam S; Huang, Ying; Miller, Sarah; Allan, John N; Bhat, Seema A; Bond, David A; Brander, Danielle M; Byrd, John C; Chavez, Julio C; Chong, Elise; Davids, Matthew S; Danilov, Alexey V; Ding, Wei; Dowling, Mark R; Dvorak-Kornaus, Kaitlyn; Freedman, Hannah; Hampel, Paul J; Ho, Carrie; Hwang, Steven R; Islam, Prioty; Malakhov, Nikita; Matasar, Matthew; Miller, Cecelia; Omer, Zulfa; Parikh, Sameer A; Parry, Erin; Rabe, Kari G; Raess, Philipp W; Rai, Manoj; Roeker, Lindsey; Rhodes, Joanna; Rogers, Kerry A; Saha, Aditi; Schade, Jake; Scott, Hamish W; Shadman, Mazyar; Shouse, Geoffrey; Skarbnik, Alan; Spurgeon, Stephen; Stephens, Deborah M; Thompson, Meghan C; Thompson, Philip A; Wang, Yucai; Yano, Max; Woyach, Jennifer A

Comparison of axicabtagene ciloleucel and tisagenlecleucel patient CAR-T cell products by single-cell RNA sequencing

通过单细胞RNA测序比较axicabtagene ciloleucel和tisagenlecleucel患者CAR-T细胞产品

Yu, Xiaoqing; Jain, Michael D; Menges, Meghan A; Cen, Ling; Noble, Jerald D; Atkins, Reginald; Mohammad, Turab J; Bachmeier, Christina A; Naderinezhad, Samira; Reid, Kayla; Corallo, Salvatore; Yoder, Sean J; Zhang, Chaomei; Zhang, Lanmin; Miranda, Julieta Abraham; Shah, Bijal; Chavez, Julio C; Hesterberg, Rebecca S; Delgado, Luis Cuadrado; Savid-Frontera, Constanza; Rodriguez, Paulo C; Cleveland, John L; Wang, Xuefeng; Davila, Marco L; Locke, Frederick L

Mitigating T-cell mitochondrial dysfunction in CLL to augment CAR T-cell therapy: evaluation in an immunocompetent model.

减轻 CLL 中的 T 细胞线粒体功能障碍以增强 CAR T 细胞疗法:在免疫功能健全的模型中进行评估

Gamal Wael, Goedhart Nienke B, Simon-Molas Helga, Mediavilla-Varela Melanie, Uriepero-Palma Angimar, Peters Fleur S, Maharaj Kamira, Chavez Julio C, Powers John, Obermayer Alyssa, Shaw Timothy I, Conejo-Garcia José R, Rodriguez Paulo C, Sahakian Eva, Pinilla-Ibarz Javier, Kater Arnon P

Leveraging the Immunomodulatory Potential of Ibrutinib for Improved Outcomes of T Cell-Mediated Therapies of B Cell Malignancies: A Narrative Review

利用伊布替尼的免疫调节潜力改善T细胞介导的B细胞恶性肿瘤治疗效果:一篇叙述性综述

Miklos, David B; Riedell, Peter A; Bokun, Alex; Chavez, Julio C; Schuster, Stephen J

Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium

大B细胞淋巴瘤标准治疗方案Axicabtagene Ciloleucel的五年随访:来自美国淋巴瘤CAR-T细胞治疗联盟的结果

Jain, Michael D; Spiegel, Jay Y; Nastoupil, Loretta J; Tamaresis, John; Ghobadi, Armin; Lin, Yi; Lekakis, Lazaros; Reagan, Patrick; Oluwole, Olalekan; McGuirk, Joseph; Deol, Abhinav; Dorritie, Kathleen A; Sehgal, Alison R; Goy, Andre; Hill, Brian T; Andreadis, Charalambos; Munoz, Javier; Ulrickson, Matthew; Westin, Jason; Chavez, Julio C; Patel, Dilan; Jacobs, Miriam T; Bansal, Radhika; Bennani, N Nora; Patel, Vivek G; Rapoport, Aaron P; Vose, Julie M; Miklos, David B; Neelapu, Sattva S; Locke, Frederick L; Lunning, Matthew; Dahiya, Saurabh

Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update

tisagenlecleucel治疗复发/难治性滤泡性淋巴瘤成人患者后获得持久疗效:ELARA试验最新进展

Dreyling, Martin; Fowler, Nathan Hale; Dickinson, Michael; Martinez-Lopez, Joaquin; Kolstad, Arne; Butler, Jason; Ghosh, Monalisa; Popplewell, Leslie; Chavez, Julio C; Bachy, Emmanuel; Kato, Koji; Harigae, Hideo; Kersten, Marie José; Andreadis, Charalambos; Riedell, Peter A; Ho, P Joy; Pérez-Simón, José Antonio; Chen, Andy I; Nastoupil, Loretta J; von Tresckow, Bastian; María Ferreri, Andrés José; Teshima, Takanori; Patten, Piers E M; McGuirk, Joseph P; Petzer, Andreas L; Offner, Fritz; Viardot, Andreas; Zinzani, Pier Luigi; Malladi, Ram; Paule, Ines; Zia, Aiesha; Awasthi, Rakesh; Han, Xia; Germano, Davide; O'Donovan, Darragh; Ramos, Roberto; Maier, Harald J; Masood, Aisha; Thieblemont, Catherine; Schuster, Stephen J

Bridging therapy with axicabtagene ciloleucel for large B-cell lymphoma: results from the US Lymphoma CAR-T Consortium

使用 axicabtagene ciloleucel 进行大 B 细胞淋巴瘤桥接治疗:来自美国淋巴瘤 CAR-T 联盟的结果

Jain, Michael D; Jacobs, Miriam T; Gao, Feng; Nastoupil, Loretta J; Spiegel, Jay Y; Lin, Yi; Dahiya, Saurabh; Lunning, Matthew; Lekakis, Lazaros; Reagan, Patrick; Oluwole, Olalekan; McGuirk, Joseph; Deol, Abhinav; Sehgal, Alison R; Goy, Andre; Hill, Brian T; Andreadis, Charalambos; Munoz, Javier; Chavez, Julio C; Bennani, N Nora; Rapoport, Aaron P; Vose, Julie M; Miklos, David; Neelapu, Sattva S; Locke, Frederick L; Ghobadi, Armin

Evaluation of prognostic factors in patients with high-risk classical Hodgkin lymphoma undergoing autologous transplantation

对接受自体移植的高危经典型霍奇金淋巴瘤患者预后因素的评估

Epperla, Narendranath; Huang, Ying; Cashen, Amanda F; Vaughn, John L; Hanel, Walter; Badar, Talha; Barta, Stefan K; Caimi, Paolo F; Sethi, Tarsheen K; Reddy, Nishitha; Karmali, Reem; Bello, Celeste; Chavez, Julio C; Kothari, Shalin K; Hernandez-Ilizaliturri, Francisco J; Svoboda, Jakub; Lansigan, Frederick; Glenn, Martha J; Cohen, Jonathon B; Sorge, Caryn; Christian, Beth; Herrera, Alex F; Hamadani, Mehdi; Costa, Luciano J; Xavier, Ana C